This topic contains a solution. Click here to go to the answer

Author Question: An oncology nurse is reviewing the medication administration record of a patient being treated for ... (Read 126 times)

tfester

  • Hero Member
  • *****
  • Posts: 534
An oncology nurse is reviewing the medication administration record of a patient being treated for advanced prostate cancer. In addition to two chemotherapeutic agents, the nurse reads that the patient has been ordered a cytoprotective agent.
 
  The goal of this agent is to A) buffer the cytotoxins that result from the metabolism of chemotherapeutic agents.
  B) protect the patient from pathophysiological effects of his malignancy.
  C) potentiate the beneficial effects of chemotherapy.
  D) reduce the incidence or severity of adverse drug effects.

Question 2

A 4-year-old child has eaten his mother's prenatal vitamins. Which medication is indicated for iron toxicity?
 
  A) Deferoxamine (Desferal)
  B) Penicillamine (Cuprimine)
  C) Sucralfate (Carafate)
  D) Magnesium sulfate



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

snackralk

  • Sr. Member
  • ****
  • Posts: 363
Answer to Question 1

D
Feedback:
Cytoprotectant agents reduce the adverse effects of cytotoxic drugs, some of which can be severe, debilitating, or life threatening. Cytoprotectant drugs do not potentiate chemotherapy, protect the patient from the effects of cancer, or buffer cytotoxins.

Answer to Question 2

A





 

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library